DUBLIN, Ohio--([ BUSINESS WIRE ])--Navidea Biopharmaceuticals, Inc. (NYSEMKT: NAVB), a biopharmaceutical company focused on the development and commercialization of precision diagnostics and radiopharmaceutical agents, today posted on its website an update to the status of the Lymphoseek NDA review. The web access to the statement can be found on the Navidea Investor page at: [ http://phx.corporate-ir.net/phoenix.zhtml?c=68527&p=irol-nda ].


[ Tue, Sep 25th 2012
] - WOPRAI
[ Tue, Sep 25th 2012
] - WOPRAI
[ Tue, Sep 25th 2012
] - Market Wire
[ Tue, Sep 25th 2012
] - Market Wire
[ Tue, Sep 25th 2012
] - Market Wire
[ Tue, Sep 25th 2012
] - Market Wire
[ Tue, Sep 25th 2012
] - Market Wire
[ Tue, Sep 25th 2012
] - Market Wire
[ Tue, Sep 25th 2012
] - Market Wire
[ Tue, Sep 25th 2012
] - Market Wire
[ Tue, Sep 25th 2012
] - WOPRAI
[ Tue, Sep 25th 2012
] - WOPRAI
[ Tue, Sep 25th 2012
] - Market Wire
[ Tue, Sep 25th 2012
] - Market Wire
[ Tue, Sep 25th 2012
] - Market Wire
[ Tue, Sep 25th 2012
] - Market Wire
[ Tue, Sep 25th 2012
] - Market Wire
[ Tue, Sep 25th 2012
] - Market Wire
[ Tue, Sep 25th 2012
] - Market Wire
[ Tue, Sep 25th 2012
] - Market Wire
[ Tue, Sep 25th 2012
] - Market Wire
[ Tue, Sep 25th 2012
] - Market Wire
[ Tue, Sep 25th 2012
] - Market Wire
[ Tue, Sep 25th 2012
] - WOPRAI
[ Tue, Sep 25th 2012
] - WOPRAI
[ Tue, Sep 25th 2012
] - WOPRAI
[ Tue, Sep 25th 2012
] - WOPRAI
[ Tue, Sep 25th 2012
] - WOPRAI

[ Mon, Sep 24th 2012
] - Market Wire
[ Mon, Sep 24th 2012
] - Market Wire
[ Mon, Sep 24th 2012
] - Market Wire
[ Mon, Sep 24th 2012
] - Market Wire
[ Mon, Sep 24th 2012
] - Market Wire
[ Mon, Sep 24th 2012
] - Market Wire
[ Mon, Sep 24th 2012
] - Market Wire
[ Mon, Sep 24th 2012
] - WOPRAI
[ Mon, Sep 24th 2012
] - WOPRAI
[ Mon, Sep 24th 2012
] - WOPRAI
[ Mon, Sep 24th 2012
] - WOPRAI
[ Mon, Sep 24th 2012
] - WOPRAI
[ Mon, Sep 24th 2012
] - WOPRAI
[ Mon, Sep 24th 2012
] - Market Wire
[ Mon, Sep 24th 2012
] - Market Wire
[ Mon, Sep 24th 2012
] - Market Wire
[ Mon, Sep 24th 2012
] - Market Wire
[ Mon, Sep 24th 2012
] - Market Wire
[ Mon, Sep 24th 2012
] - Market Wire
[ Mon, Sep 24th 2012
] - Market Wire
[ Mon, Sep 24th 2012
] - Market Wire
[ Mon, Sep 24th 2012
] - Market Wire
[ Mon, Sep 24th 2012
] - Market Wire
[ Mon, Sep 24th 2012
] - Market Wire
[ Mon, Sep 24th 2012
] - Market Wire
[ Mon, Sep 24th 2012
] - Market Wire
[ Mon, Sep 24th 2012
] - Market Wire
[ Mon, Sep 24th 2012
] - Market Wire
[ Mon, Sep 24th 2012
] - Market Wire
[ Mon, Sep 24th 2012
] - Market Wire
[ Mon, Sep 24th 2012
] - Market Wire
[ Mon, Sep 24th 2012
] - Market Wire
[ Mon, Sep 24th 2012
] - Market Wire
[ Mon, Sep 24th 2012
] - Market Wire
[ Mon, Sep 24th 2012
] - Market Wire
[ Mon, Sep 24th 2012
] - Market Wire
[ Mon, Sep 24th 2012
] - WOPRAI
[ Mon, Sep 24th 2012
] - Market Wire
[ Mon, Sep 24th 2012
] - Market Wire
[ Mon, Sep 24th 2012
] - Market Wire
[ Mon, Sep 24th 2012
] - Market Wire
[ Mon, Sep 24th 2012
] - Market Wire
[ Mon, Sep 24th 2012
] - Market Wire
[ Mon, Sep 24th 2012
] - Market Wire
[ Mon, Sep 24th 2012
] - Market Wire
[ Mon, Sep 24th 2012
] - Market Wire
[ Mon, Sep 24th 2012
] - Market Wire
[ Mon, Sep 24th 2012
] - Market Wire
[ Mon, Sep 24th 2012
] - Market Wire
[ Mon, Sep 24th 2012
] - Market Wire
[ Mon, Sep 24th 2012
] - Market Wire
[ Mon, Sep 24th 2012
] - Market Wire
[ Mon, Sep 24th 2012
] - Market Wire
[ Mon, Sep 24th 2012
] - Market Wire
[ Mon, Sep 24th 2012
] - Market Wire
[ Mon, Sep 24th 2012
] - Market Wire
[ Mon, Sep 24th 2012
] - Market Wire
[ Mon, Sep 24th 2012
] - Market Wire
[ Mon, Sep 24th 2012
] - Market Wire
[ Mon, Sep 24th 2012
] - Market Wire
[ Mon, Sep 24th 2012
] - Market Wire
[ Mon, Sep 24th 2012
] - Market Wire